Published in Z Rheumatol on April 01, 2014
Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2008) 6.18
Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report. Arthritis Rheum (2003) 5.29
What does epidemiology tell us about risk factors for herpes zoster? Lancet Infect Dis (2004) 4.87
Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study. Arthritis Rheum (2002) 4.69
Aging of the immune system: how much can the adaptive immune system adapt? Immunity (2006) 4.30
Risk of herpes zoster in patients with rheumatoid arthritis treated with anti-TNF-alpha agents. JAMA (2009) 3.90
Ageing and infection. Lancet Infect Dis (2002) 3.79
Predictors of infection in rheumatoid arthritis. Arthritis Rheum (2002) 3.47
Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6 months of treatment: updated results from the British Society for Rheumatology Biologics Register with special emphasis on risks in the elderly. Rheumatology (Oxford) (2010) 3.04
Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three-year prospective French Research Axed on Tolerance of Biotherapies registry. Arthritis Rheum (2009) 2.92
Treatment benefit or survival of the fittest: what drives the time-dependent decrease in serious infection rates under TNF inhibition and what does this imply for the individual patient? Ann Rheum Dis (2011) 2.67
Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR). Ann Rheum Dis (2009) 2.65
Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists. Arthritis Rheum (2005) 2.35
The risk of herpes zoster in patients with rheumatoid arthritis in the United States and the United Kingdom. Arthritis Rheum (2007) 2.16
Incidence of infection in systemic lupus erythematosus. Arthritis Rheum (1974) 1.89
[Prophylaxis, diagnosis and therapy of hepatitis C virus (HCV) infection: the German guidelines on the management of HCV infection]. Z Gastroenterol (2010) 1.76
Screening for latent tuberculosis infection: performance of tuberculin skin test and interferon-γ release assays under real-life conditions. Ann Rheum Dis (2012) 1.46
Prophylaxis for latent tuberculosis infection prior to anti–tumor necrosis factor therapy in low-risk elderly patients with rheumatoid arthritis: a decision analysis. Arthritis Care Res (Hoboken) (2013) 1.41
Influence of replacing tuberculin skin test with ex vivo interferon γ release assays on decision to administer prophylactic antituberculosis antibiotics before anti-TNF therapy. Ann Rheum Dis (2012) 1.39
[Prophylaxis, diagnosis and therapy of hepatitis B virus infection - the German guideline]. Z Gastroenterol (2011) 1.24
Immunosenescence and Challenges of Vaccination against Influenza in the Aging Population. Aging Dis (2011) 1.23
Serious infections in a population-based cohort of 86,039 seniors with rheumatoid arthritis. Arthritis Care Res (Hoboken) (2013) 1.10
Abatacept and reduced immune response to pandemic 2009 influenza A/H1N1 vaccination in patients with rheumatoid arthritis. Arthritis Care Res (Hoboken) (2013) 1.09
The janus head of T cell aging - autoimmunity and immunodeficiency. Front Immunol (2013) 1.09
Infection in systemic lupus erythematosus. Rheum Dis Clin North Am (1998) 1.08
Immunosenescence and novel vaccination strategies for the elderly. Front Immunol (2013) 1.07
Infections in systemic lupus erythematosus: a prospective and controlled study of 110 patients. Lupus (2006) 1.05
The influence of systemic glucocorticoid therapy upon the risk of non-serious infection in older patients with rheumatoid arthritis: a nested case-control study. Ann Rheum Dis (2011) 1.04
Development and validation of a risk score for serious infection in patients with rheumatoid arthritis. Arthritis Rheum (2012) 1.03
You can't always get what you want, but if you try sometimes (with two tests--TST and IGRA--for tuberculosis) you get what you need. Ann Rheum Dis (2012) 0.99
Use of a disease risk score to compare serious infections associated with anti-tumor necrosis factor therapy among high- versus lower-risk rheumatoid arthritis patients. Arthritis Care Res (Hoboken) (2012) 0.96
[Recommendations for tuberculosis screening before initiation of TNF-alpha-inhibitor treatment in rheumatic diseases]. Pneumologie (2009) 0.95
Vaccination survey in patients with rheumatoid arthritis: a cross-sectional study. Rheumatol Int (2011) 0.94
Evaluation of the RABBIT Risk Score for serious infections. Ann Rheum Dis (2013) 0.89
The effect of smoking and alcohol consumption on markers of systemic inflammation, immunoglobulin levels and immune response following pneumococcal vaccination in patients with arthritis. Arthritis Res Ther (2012) 0.87
[Vaccination in adult patients with chronic inflammatory rheumatic diseases]. Z Rheumatol (2013) 0.84
[Vaccination recommendations of the Commission for Pharmacotherapy of the German Society of Rheumatology]. Z Rheumatol (2013) 0.83
[Pneumococcus vaccination in immunosuppressed patients: current recommendations]. Z Rheumatol (2013) 0.77
Bacteraemia in the very old. Features and treatment. Drugs Aging (1995) 0.77